Global DTC Genetic Testing Market Size, Status and Forecast 2021-2027

Direct-to-consumer genetic testing is different: these genetic tests are marketed directly to customers via television, print advertisements, or the Internet, and the tests can be bought online or in stores. Customers send the company a DNA sample and receive their results directly from a secure website or in a written report. Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process.

Market Analysis and Insights: Global DTC Genetic Testing Market
The global DTC Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global DTC Genetic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global DTC Genetic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global DTC Genetic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global DTC Genetic Testing market.

Global DTC Genetic Testing Scope and Market Size
DTC Genetic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DTC Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Analysis
Single Nucleotide Polymorphism (SNP) Chips
Whole Genome Sequencing (WGS)

Segment by Application
Carrier Testing
Predictive Testing
Ancestry and Relationship Testing
Nutrigenomics Testing
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
23andMe
Ancestry
Color
EasyDNA
Family Tree DNA（Gene by Gene）
Full Genomes
Genesis HealthCare
Helix
Identigene
Karmagenes
Living DNA
MapMyGenome
MyHeritage
Pathway Genomics